Literature DB >> 22081254

Identification of novel hybrids between Cryptococcus neoformans var. grubii VNI and Cryptococcus gattii VGII.

Mojgan Aminnejad1, Mara Diaz, Michael Arabatzis, Elizabeth Castañeda, Marcia Lazera, Aristea Velegraki, Deborah Marriott, Tania C Sorrell, Wieland Meyer.   

Abstract

Cryptococcus neoformans and Cryptococcus gattii are pathogenic yeasts causing meningoencephalitis in immunocompromised and immunocompetent hosts. The fungus is typically haploid, and sexual reproduction occurs normally between individuals with opposite mating types, α and a. C. neoformans var. grubii (serotype A) is comprised of molecular types VNI, VNII, and VNB, and C. neoformans var. neoformans (serotype D) contains the molecular type VNIV. Additionally, diploid or aneuploid AD hybrids (VNIII) have been reported. C. gattii contains the molecular types VGI, VGII, VGIII, and VGIV, which encompass both serotypes B and C. To identify possible hybrid strains, URA5-RFLP analysis was performed on 350 globally obtained clinical, environmental, and veterinary isolates. Four clinical isolates from cerebrospinal fluid showed combination patterns of C. neoformans var. grubii and C. gattii: Brazil (n = 2), Colombia (n = 1), and India (n = 1). These strains were monokaryotic and diploid or aneuploid. M13 PCR fingerprinting showed that they contained fragments of both proposed parental groups. Luminex IGS genotyping identified these isolates as hybrids with two different molecular type combinations: three VNI/VGII and one VNI/VGI. Blue color development on CGB agar was delayed in three isolates and absent in one. C. gattii-specific PCR confirmed the presence of C. gattii in the hybrids. CAP59 allele-specific PCR revealed that all the hybrids contained both serotype A and B alleles. Determination of mating-type allelic patterns by PCR revealed that the isolates were αA aB. This is the first study discovering novel natural hybrids between C. neoformans molecular type VNI and C. gattii molecular type VGII.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22081254     DOI: 10.1007/s11046-011-9491-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  16 in total

1.  Cryptococcal meningitis caused by Cryptococcus neoformans var. gattii, serotype C, in AIDS patients in Soweto, South Africa.

Authors:  A S Karstaedt; H H Crewe-Brown; F Dromer
Journal:  Med Mycol       Date:  2002-02       Impact factor: 4.076

2.  Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure.

Authors:  S P Franzot; J S Hamdan; B P Currie; A Casadevall
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  First case of human cryptococcosis due to Cryptococcus neoformans var. gattii in Spain.

Authors:  M Francisca Colom; Susana Frasés; Consuelo Ferrer; Alejandro Jover; Mariano Andreu; Sergio Reus; Manuel Sánchez; Josep M Torres-Rodríguez
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Molecular analysis of 311 Cryptococcus neoformans isolates from a 30-month ECMM survey of cryptococcosis in Europe.

Authors:  Maria Anna Viviani; Massimo Cogliati; Maria Carmela Esposto; Karin Lemmer; Kathrin Tintelnot; Maria Francisca Colom Valiente; Danielle Swinne; Aristea Velegraki; Rosa Velho
Journal:  FEMS Yeast Res       Date:  2006-06       Impact factor: 2.796

Review 5.  The biology of the Cryptococcus neoformans species complex.

Authors:  Xiaorong Lin; Joseph Heitman
Journal:  Annu Rev Microbiol       Date:  2006       Impact factor: 15.500

6.  Recapitulation of the sexual cycle of the primary fungal pathogen Cryptococcus neoformans var. gattii: implications for an outbreak on Vancouver Island, Canada.

Authors:  James A Fraser; Ryan L Subaran; Connie B Nichols; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2003-10

7.  Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States.

Authors:  Edmond J Byrnes; Wenjun Li; Yonathan Lewit; Hansong Ma; Kerstin Voelz; Ping Ren; Dee A Carter; Vishnu Chaturvedi; Robert J Bildfell; Robin C May; Joseph Heitman
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

8.  Molecular typing of IberoAmerican Cryptococcus neoformans isolates.

Authors:  Wieland Meyer; Alexandra Castañeda; Stuart Jackson; Matthew Huynh; Elizabeth Castañeda
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

9.  First report of Cryptococcus neoformans var. gattii serotype B from Greece.

Authors:  A Velegraki; V G Kiosses; H Pitsouni; D Toukas; V D Daniilidis; N J Legakis
Journal:  Med Mycol       Date:  2001-10       Impact factor: 4.076

10.  Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City.

Authors:  B P Currie; A Casadevall
Journal:  Clin Infect Dis       Date:  1994-12       Impact factor: 9.079

View more
  33 in total

1.  Cryptococcus and cryptococcosis in the twenty-first century.

Authors:  Maurizio Del Poeta; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2012-06       Impact factor: 2.574

2.  Cryptococcus gattii as an important fungal pathogen of western North America.

Authors:  Kieren A Marr
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

3.  Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population.

Authors:  Ferry Hagen; María-Teresa Illnait-Zaragozí; Jacques F Meis; William H M Chew; Ilse Curfs-Breuker; Johan W Mouton; Andy I M Hoepelman; Lodewijk Spanjaard; Paul E Verweij; Greetje A Kampinga; Ed J Kuijper; Teun Boekhout; Corné H W Klaassen
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

Review 4.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Fungal evolution: cellular, genomic and metabolic complexity.

Authors:  Miguel A Naranjo-Ortiz; Toni Gabaldón
Journal:  Biol Rev Camb Philos Soc       Date:  2020-04-17

6.  Cryptococcus gattii, no longer an accidental pathogen?

Authors:  Deborah J Springer; Sujal Phadke; Blake Billmyre; Joseph Heitman
Journal:  Curr Fungal Infect Rep       Date:  2012-12

Review 7.  Evolutionary role of interspecies hybridization and genetic exchanges in yeasts.

Authors:  Lucia Morales; Bernard Dujon
Journal:  Microbiol Mol Biol Rev       Date:  2012-12       Impact factor: 11.056

8.  Isolation, Identification and Molecular Typing of Cryptococcus neoformans from Pigeon Droppings and Other Environmental Sources in Tripoli, Libya.

Authors:  Mohamed S Ellabib; Mohamed A Aboshkiwa; Walid M Husien; Roberta D'Amicis; Massimo Cogliati
Journal:  Mycopathologia       Date:  2016-03-04       Impact factor: 2.574

9.  Molecular Characterization and Antifungal Susceptibility Testing of Sequentially Obtained Clinical Cryptococcus deneoformans and Cryptococcus neoformans Isolates from Ljubljana, Slovenia.

Authors:  Rok Tomazin; Tadeja Matos; Jacques F Meis; Ferry Hagen
Journal:  Mycopathologia       Date:  2017-10-24       Impact factor: 2.574

10.  MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.

Authors:  Carolina Firacative; Luciana Trilles; Wieland Meyer
Journal:  PLoS One       Date:  2012-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.